Detecting signs of Fabry and Pompe disease in UK clinical data
Volv, supported by Sanofi, and working with Optimum Patient Care, and collaborating with a specialist Consultant Clinician, is performing research to build algorithms in the UK which are aimed at finding ways to better identify people living with Fabry or Pompe disease.
This novel and innovative methodology, inTrigue, is highlighting ways in which we can be much more precise in detecting people living with either disease much earlier.
Are you a Fabry or Pompe specialist in the UK and want to know more, or collaborate? Please contact us.